{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:35:07Z","timestamp":1768480507164,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Helen MacPherson Smith Trust","award":["7124"],"award-info":[{"award-number":["7124"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Practitioner fellowship"],"award-info":[{"award-number":["Practitioner fellowship"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010552","name":"College of Science, Engineering and Health, Royal Melbourne Institute of Technology","doi-asserted-by":"crossref","award":["School of Health & Biomedical Sciences"],"award-info":[{"award-number":["School of Health & Biomedical Sciences"]}],"id":[{"id":"10.13039\/100010552","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12958-019-0472-0","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T06:03:01Z","timestamp":1552716181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Expression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (PCOS) state"],"prefix":"10.1186","volume":"17","author":[{"given":"Genia F.","family":"Burchall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dodie S.","family":"Pouniotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena J.","family":"Teede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeeva","family":"Ranasinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty A.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence J.","family":"Piva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"issue":"1","key":"472_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"2","key":"472_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544\u201351.","journal-title":"Hum Reprod"},{"issue":"6","key":"472_CR3","doi-asserted-by":"publisher","first-page":"s65","DOI":"10.5694\/mja11.10915","volume":"195","author":"HJ Teede","year":"2011","unstructured":"Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195(6):s65\u2013s112.","journal-title":"Med J Aust"},{"issue":"10","key":"472_CR4","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067\u201373.","journal-title":"Hum Reprod"},{"issue":"9","key":"472_CR5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"3","key":"472_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364\u201379.","journal-title":"Fertil Steril"},{"issue":"3","key":"472_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cen.13795","volume":"89","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. 2018;89(3):251\u201368.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"472_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tcm.2012.01.001","volume":"21","author":"G Burchall","year":"2011","unstructured":"Burchall G, Linden MD, Teede H, Piva TJ. Hemostatic abnormalities and relationships to metabolic and hormonal status in polycystic ovarian syndrome. Trends Cardiovasc Med. 2011;21(1):6\u201314.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"472_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0035-1564837","volume":"42","author":"GF Burchall","year":"2016","unstructured":"Burchall GF, Piva TJ, Linden MD, Gibson-Helm ME, Ranasinha S, Teede HJ. Comprehensive assessment of the hemostatic system in polycystic ovarian syndrome. Semin Thromb Hemost. 2016;42(1):55\u201362.","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"472_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1095\/biolreprod43.4.636","volume":"43","author":"I Politis","year":"1990","unstructured":"Politis I, Srikandakumar A, Turner JD, Tsang BK, Ainsworth L, Downey BR. Changes in and partial identification of the plasminogen activator and plasminogen activator inhibitor systems during ovarian follicular maturation in the pig. Biol Reprod. 1990;43(4):636\u201342.","journal-title":"Biol Reprod"},{"issue":"1","key":"472_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1677\/JME-06-0057","volume":"39","author":"JK Devin","year":"2007","unstructured":"Devin JK, Johnson JE, Eren M, Gleaves LA, Bradham WS, Bloodworth JR Jr, et al. Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice. J Mol Endocrinol. 2007;39(1):9\u201316.","journal-title":"J Mol Endocrinol"},{"key":"472_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2741\/4128","volume":"18","author":"YX Liu","year":"2013","unstructured":"Liu YX, Liu XM, Nin LF, Shi L, Chen SR. Serine protease and ovarian paracrine factors in regulation of ovulation. Front Biosci (Landmark Ed). 2013;18:650\u201364.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"472_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2337\/diabetes.53.2.336","volume":"53","author":"LJ Ma","year":"2004","unstructured":"Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes. 2004;53(2):336\u201346.","journal-title":"Diabetes."},{"issue":"3","key":"472_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0092-8674(75)90187-7","volume":"6","author":"WH Beers","year":"1975","unstructured":"Beers WH. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell. 1975;6(3):379\u201386.","journal-title":"Cell."},{"issue":"2","key":"472_CR15","first-page":"518","volume":"76","author":"GN Piquette","year":"1993","unstructured":"Piquette GN, Crabtree ME, el-Danasouri I, Milki A, Polan ML. Regulation of plasminogen activator inhibitor-1 and -2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells. J Clin Endocrinol Metab. 1993;76(2):518\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"472_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/09513590009167677","volume":"14","author":"WU Atiomo","year":"2000","unstructured":"Atiomo WU, Hilton D, Fox R, Lee D, Shaw S, Friend J, et al. Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries. Gynecol Endocrinol. 2000;14(3):162\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"472_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1210\/jc.2014-2086","volume":"100","author":"AS Ambekar","year":"2015","unstructured":"Ambekar AS, Kelkar DS, Pinto SM, Sharma R, Hinduja I, Zaveri K, et al. Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development. J Clin Endocrinol Metab. 2015;100(2):744\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"472_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/humrep\/des460","volume":"28","author":"A Pierre","year":"2013","unstructured":"Pierre A, Peigne M, Grynberg M, Arouche N, Taieb J, Hesters L, et al. Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum Reprod. 2013;28(3):762\u20139.","journal-title":"Hum Reprod"},{"issue":"5","key":"472_CR19","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 2010;95(5):2038\u201349.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"472_CR20","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"AS Caldwell","year":"2014","unstructured":"Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146\u201359.","journal-title":"Endocrinology."},{"issue":"8","key":"472_CR21","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1210\/en.2007-0248","volume":"148","author":"KA Walters","year":"2007","unstructured":"Walters KA, Allan CM, Jimenez M, Lim PR, Davey RA, Zajac JD, et al. Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility. Endocrinology. 2007;148(8):3674\u201384.","journal-title":"Endocrinology."},{"issue":"3","key":"472_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12672-012-0107-9","volume":"3","author":"U Simanainen","year":"2012","unstructured":"Simanainen U, Gao YR, Walters KA, Watson G, Desai R, Jimenez M, et al. Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors. Horm Cancer. 2012;3(3):113\u201324.","journal-title":"Horm Cancer"},{"issue":"5","key":"472_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/rep.1.00095","volume":"127","author":"M Myers","year":"2004","unstructured":"Myers M, Britt KL, Wreford NGM, Ebling FJP, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127(5):569\u201380.","journal-title":"Reproduction."},{"issue":"2","key":"472_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1432-1033.1991.tb15736.x","volume":"195","author":"YX Liu","year":"1991","unstructured":"Liu YX, Peng XR, Ny T. Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type-I and tissue-type plasminogen-activator in the rat ovary during gonadotropin-induced ovulation. Eur J Biochem. 1991;195(2):549\u201355.","journal-title":"Eur J Biochem"},{"issue":"2","key":"472_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0303-7207(97)00152-4","volume":"133","author":"K Liu","year":"1997","unstructured":"Liu K, Liu YX, Hu ZY, Zou RY, Chen YJ, Mu XM, et al. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression. Mol Cell Endocrinol. 1997;133(2):109\u201316.","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"472_CR26","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1210\/en.2003-0304","volume":"144","author":"K Liu","year":"2003","unstructured":"Liu K, Feng Q, Gao HJ, Hu ZY, Zou RJ, Li YC, et al. Expression and regulation of plasminogen activators, plasminogen activator inhibitor type-1, and steroidogenic acute regulatory protein in the rhesus monkey corpus luteum. Endocrinology. 2003;144(8):3611\u20137.","journal-title":"Endocrinology."}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-019-0472-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-019-0472-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-019-0472-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,15]],"date-time":"2020-03-15T00:04:27Z","timestamp":1584230667000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-019-0472-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1186\/s12958-019-0472-0","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]},"assertion":[{"value":"16 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Procedures were approved by the Sydney Local Health District Animal Welfare Committee as fulfilling NHMRC guidelines for animal experimentation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"33"}}